Methemoglobinemia diagnostic study of choice

Revision as of 04:08, 22 January 2019 by Shyam Patel (talk | contribs) (→‎Diagnostic results)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Methemoglobinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Methemoglobinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Methemoglobinemia diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Methemoglobinemia diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Methemoglobinemia diagnostic study of choice

on Methemoglobinemia diagnostic study of choice

Methemoglobinemia diagnostic study of choice in the news

Blogs on Methemoglobinemia diagnostic study of choice

Directions to Hospitals Treating Methemoglobinemia

Risk calculators and risk factors for Methemoglobinemia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aksiniya Stevasarova, M.D.

Overview

The diagnostic study of choice for methemoglobinemia is direct measurement of methemoglobin by a multiple wavelength co-oximeter. Also clinical cyanosis in the presence of normal arterial oxygen tensions is highly suggestive of methemoglobinemia.

Diagnostic Study of Choice

Study of choice

Direct measurement of methemoglobin by a multiple wavelength co-oximeter is the gold standard test for the diagnosis of methemoglobinemia.

Co-oximetry

The co-oximeter is the most accurate device to measure methemoglobin. The newer generation devices can actually differentiate between methemoglobin, carboxyhemoglobin, oxyhemoglobin, deoxyhemoglobin, and also sulfhemoglobin.[1]


The comparison of various diagnostic studies for methemoglobinemia

Test Sensitivity Specificity
Co-oximetry 100% 100%
Pulse-oximetry 85% 85%

[Co-oximetry] is the preferred investigation based on the sensitivity and specificity

Diagnostic results

In methemoglobinemia patients, we often see the so called “saturation gap” which can help us diagnose the condition. The gap is calculated by subtracting the oxygen percentage from the ABG analysis (typically normal in methemoglobinemia patients 100%) from the percentage of oxygen saturation given by the pulse oximeter (always ~85% in methemoglobinemia patients). Saturation gap more than 5% is significant.

The following finding on performing saturation gap is confirmatory for methemoglobinemia:

Sequence of Diagnostic Studies

The various investigations must be performed in the following order:

  • Direct measurement with co-oximetry
  • Calculation of the saturation gap
  • The pulse oximetry in methemoglobinemia patients is inaccurate and unreliable, and will always show a value around 85%, regardless of the level of MetHb in the blood. This is very important to know as this value can be misleading especially in patients with very high MetHb levels. Fortunately new multiwavelength pulse oximeters have been developed recently and they can detect the levels of MetHb more accurately. [2]

Name of Diagnostic Criteria

There are no established criteria for the diagnosis of methemoglobinemia.

References

  1. Feiner JR, Bickler PE, Mannheimer PD (2010). "Accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia". Anesth Analg. 111 (1): 143–8. doi:10.1213/ANE.0b013e3181c91bb6. PMID 20007731.
  2. Van Leeuwen SR, Baranoski GVG, Kimmel BW (2017). "Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood". Conf Proc IEEE Eng Med Biol Soc. 2017: 4570–4573. doi:10.1109/EMBC.2017.8037873. PMID 29060914.

Template:WH Template:WS